Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer (Q64042037)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer |
clinical trial |
Statements
EXAM (English)
0 references
An International, Randomized, Double-Blinded, Phase 3 Efficacy Study of XL184 Versus Placebo in Subjects With Unresectable, Locally Advanced, or Metastatic Medullary Thyroid Cancer (English)
0 references
June 2008
0 references
October 2011
0 references
330
0 references
18 year
0 references